REFERENCES
- Carstensen J. T. Pharmaceutical Preformulation. Technomic Publishing Co., Lancaster, PA 1998
- Yu L., Reutzel S. M., Stephenson G. A. Physical characterization of polymorphic drugs: an integrated characterization strategy. Pharm. Sci. Technol. 1998; 1: 118–127
- Morris K. R., Fakes M. G., Thakur A. B., Newmann A. W., Singh A. K., Venit J. J., Spagnuolo C. J., Serajuddin A. T. M. An integrated approach to the selection of optimal salt form for a new drug candidate. Int. J. Pharm. 1994; 105: 209–217
- Morris K. R., Newman A. W., Bugay D. E., Ranadive S. A., Singh A. K., Szyper M., Varia S. A., Brittain H. G., Serajuddin A. T. M. Characterization of humiditydependent changes in crystal properties of a new HMGCoA reductase inhibitor in support of its dosage form development. Int. J. Pharm. 1994; 108: 195–206
- Millership J. S., Fitzpatrick A. Commonly used chiral drugs: a survey. Chirality 1993; 5: 573–576
- Koch P., McCullough J. R., Blum P. S., De Graw S. S., Krause A. C., Rubin P. D. Pharmacokinetics and safety of (s)-oxybutynin in normal healthy volunteers. FASEB 1998; 12: A142
- Li Z. J., Grant D. J. Relationship between physical properties and crystal structures of chiral drugs. J. Pharm. Sci. 1997; 86: 1073–1078
- Majuru S., Wurster D. E. Effect of composition on the tableting indices of binary powder mixtures. Pharm. Dev. Technol. 1997; 2: 313–321
- Levy R. H., Rowland M. Dissociation constants of sparingly soluble substances: nonlogarithmic linear titration curves. J. Pharm. Sci. 1971; 60: 1155–1159
- Lachman L., Lieberman H. A., Kanig J. L. The Theory and Practice of Industrial Pharmacy. 3rd Ed., Lea and Febiger, Philadelphia 1986; 67–184
- Hiestand E. N., Smith D. P. Three indices for characterizing the tableting performance of materials. Adv. Ceramics 1984; 9: 47–57
- Miyamoto E., Kawashima S., Murata Y., Yamada Y., Demizu Y. Physico-chemical properties of oxybutynin. Analyst 1994; 119: 1489–1492